/ACUC.ST

ACUC.ST Stock - AcuCort AB

Q: What is the analyst price target for ACUC.ST?

Analyst price target information is not currently available for ACUC.ST.

Q: What is ACUC.ST's market cap?

Market capitalization information is not currently available for ACUC.ST.

Healthcare|Drug Manufacturers - Specialty & Generic|STO

$0.57+0.00%

+$0.00 (+0.00%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.63

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ACUC.ST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.32

52W High$0.99

52W Low$0.50

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$675,000	N/A	N/A	N/A	N/A
Gross Profit	$7.72M	$6.59M	$5.02M	$3.46M	$1.53M
Gross Margin	1143.3%	N/A	N/A	N/A	N/A
Operating Income	$-17,385,000	$-13,249,000	$-14,825,000	$-11,295,450	$-7,748,830
Net Income	$-17,398,000	$-13,691,000	$-14,789,000	$-11,321,386	$-7,765,660
Net Margin	-2577.5%	N/A	N/A	N/A	N/A
EPS	$-0.12	$-0.16	$-0.38	$-0.29	$-0.30

Company Overview

AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions. It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment. AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.

Visit Website

Frequently Asked Questions about ACUC.ST

What is ACUC.ST's current stock price?

AcuCort AB (ACUC.ST) is currently trading at $0.57 per share. The stock has moved +0.00% today.

What is the analyst price target for ACUC.ST?

No analyst price targets are currently available for this stock.

What sector is AcuCort AB in?

AcuCort AB operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.

What is ACUC.ST's market cap?

AcuCort AB has a market capitalization of $0.13 billion, making it a small-cap company.

Does ACUC.ST pay dividends?

No, AcuCort AB does not currently pay a dividend to shareholders.